$21.63
-0.67-3%
Last update: Oct 30, 5:08 PM
Legend Biotech Corp
LEGNNASDAQ
Legend Biotech (LEGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '22 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $0.25 | $-0.14 | $-0.18 | $-0.12 | $-1.48 |
| Actual | $0.16 | $-0.03 | $0.01 | $-0.05 | $-1.40 |
| Surprise | -36.0% | +78.6% | +105.6% | +58.3% | +5.41% |
| Revenue | |||||
| Estimate | $353.3M | $306.9M | $306.0M | $276.0M | $144.7M |
| Actual | $387.5M | $305.1M | $306.3M | $272.3M | $117.0M |
| Surprise | +9.68% | -0.58% | +0.09% | -1.33% | -19.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.01 | $0.08 | $0.23 | $0.30 |
| Revenue | ||||
| Consensus | $359.9M | $382.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $0.16 | $0.25 | -36.0 % |
| Q1 | May 12, 2026 | $-0.03 | $-0.14 | 78.6 % |
| Q4 | Mar 10, 2026 | $0.01 | $-0.18 | 105.6 % |
| Q3 | Nov 12, 2025 | $-0.05 | $-0.12 | 58.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $387.50M | $353.31M | 9.68 % |
| Q1 | May 12, 2026 | $305.10M | $306.89M | -0.58 % |
| Q4 | Mar 10, 2026 | $306.30M | $306.03M | 0.09 % |
| Q3 | Nov 12, 2025 | $272.33M | $276.00M | -1.33 % |
